BNTC benitec.com Company Profit

Official company branding of benitec.com (BNTC)

Benitec Biopharma Inc. (BNTC) specializes in developing innovative drugs and vaccines using genetic modifications. The visualization of the company's market value on GURU.Markets is currently at -0.05. Business success relies on patents and medical test results, while ecosystem development is strictly governed by FDA regulations, as the mass commercial market has not yet been established.

BNTC Benitec Biopharma Inc Net Income (07/04/2022 - 10/30/2026)

Financial and market metric breakdowns for Benitec Biopharma (BNTC)

- stock value and consensus price forecast:
Market Price Benitec Corp|BNTC - Price Target Chart
- market capitalization data:
Market Capitalization Benitec Corp|BNTC - Enterprise Value
- book capitalization information:
Net Assets per Share Benitec Biopharma|BNTC - Company Net Assets|Market Cap to Book Value Multiple benitec.com|BNTC - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Benitec Biopharma Inc.|BNTC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Benitec Biopharma Inc|BNTC - Company Total Debt|Debt to Net Assets Ratio Benitec Corp|BNTC - Company Long-Term Debts|Company Short-Term Debt Benitec Biopharma|Interim Coverage Ratio benitec.com
- earnings and multiples data:
BNTC - Company Net Income
Summary company analysis:Benitec Corp (BNTC)
Signature product of Benitec

Net income measures the actual cash balance after deducting all operating and tax expenses, serving as an objective filter for market expectations. For Benitec Biopharma Inc. (BNTC), this metric depends on successes in gene therapy rather than macroeconomic cycles. By analyzing the company's profit trend, an investor can uncover hidden risks through sharp drops in yield. The stability of the curve confirms the business's resilience to external shocks, which ensures capital protection against speculative volatility.

Direct competitors

Company Net Income Tempus AI (TEM)|Company Net Income Qiagen N.V.|Company Profit IONS (ionispharma.com)|Net Profit RGEN|Net Financial Result Avidity Biosciences Inc|CRISPR Therapeutics Corp - Net Income|Profit After Payment of Taxes WGS (GeneDx Corp)|Ultragenyx Pharmaceutical - Net Profit|Company Net Income beamtx.com|SRPT: Net Profit|Net Income Twist Bioscience Inc|Net Income TXG|NTLA: Final Profit|Net Profit STOK|Company Net Income BLFS (biolifesolutions.com)|Net Profit WVE (Wave Life Sciences Ltd.)|Net Financial Result Maze Therapeutics, Inc. (MAZE)|SION - Company Net Income|Company Net Income Prime Medicine Bio|Taysha Gene Therapies (TSHA) - Company Net Income|Profit After Tax QURE (uniqure.com)|MGTX (MeiraGTx) - Net Profit|RGNX: Final Profit|Net Profit SLDB|Net Profit Ocugen Pharma (OCGN)|Company Net Income Pacific Biosciences PACB|Final Profit DSGN|RCKT - Company Net Income|4DMT (FDMT) - Net Income|LXEO: Net Profit|Korro Bio (KRRO) - Net Profit|Net Income EDIT|SLN: Final Profit|Net Profit PRQR|Net Financial Result codexis.com|Company Net Income Sangamo SGMO|NAUT: Company Profit|Metagenomi, Inc. - Net Profit|Precision BioSciences Inc. (DTIL) - Net Income|GBIO (generationbio.com) - Net Income|BOLD - Net Financial Result|XCUR (Exicure Inc.) - Net Profit|Company Net Income IMNN|Company Net Income Phio Pharmaceuticals (PHIO)|mustangbio.com - Company Profit|TransCode Therapeutics, Inc. - Net Income|Profit After Payment of Taxes BNGO (Bionano Genomics Inc.)|Applied DNA - Net Profit|bluebird bio, Inc (BLUE) - Net Income|IPA: Net Profit|Company Profit OMGA|Company Net Income Singular Genomics|Company Profit RGLS (Regulus Therapeutics, Inc.)|Net Profit SYRS|Net Profit Telesis Bio, Inc (TBIO)|Net Profit TCON (TRACON Pharmaceuticals)|unitybiotechnology.com - Company Net Income